NBIX - Neurocrine Biosciences Incorporated

$2.29 0.08 | 3.62%
Today's Range: 2.16 - 2.39
NBIX Avg. Daily Volume: 238,273
12/21/09 - 4:00 PM ET
TRADE NOW
Company Profile
Price and Volume
Recent Price 2.21
52 Week High 4.25
52 Week Low 1.94
Avg. Daily Vol. (Mil) 0.16
Beta (3 year) 0.31
Share Related Items
Mkt Cap (Mil) 86.65
Shares Out (Mil) 39.21
Float (Mil) 38.31
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.40
Current Ratio 2.40
LT Debt/ Equity 7.79
Total Debt / Equity 16.07
Valuation Ratios
Price Earnings n.a.
Price/Sales 29.45
Price/Book 80.60
Price/Cash Flow -1.30
Per Share Data
Earnings -1.85
Sales 0.08
Book Value 0.03
Cash Flow -1.73
Business Summary
The Company discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders.
General Information
12780 El Camino Real
San Diego, CA 92130
www.neurocrine.com
Industry : Drugs
Sector: Health Care
Employees: 125
CEO: Dr. Kevin C. Gorman, Ph.
Short Interest
Current Month (Mil) 1.84
Previous Month (Mil) 1.52
Short Interest Ratio (Days) 8.80
Management Effectiveness
Return on Equity n.a.
Return on Assets -94.80
Return on Investments -761.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
Latest NBIX Headlines
More Financial News for NBIX
Partner Headlines

Brokerage Partners

TheStreet Premium Services

All Services